http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 29 May 2026 17:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+28/26576283.html si-local-file:///var/storage/secattach/20260529/26576283.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+28/26576283.html Fri, 29 May 2026 17:01:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+28/26576283.html si-local-file:///var/storage/secattach/20260529/26576283.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+28/26576283.html Fri, 29 May 2026 17:01:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Calidi+Biotherapeutics%2C++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26501987.html si-local-file:///var/storage/secattach/20260515/26501987.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Calidi+Biotherapeutics%2C++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26501987.html Fri, 15 May 2026 11:11:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Calidi+Biotherapeutics%2C++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26501987.html si-local-file:///var/storage/secattach/20260515/26501987.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Calidi+Biotherapeutics%2C++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26501987.html Fri, 15 May 2026 11:11:00 -0400 CLDI O.51463149 http://www.streetinsider.com/Earnings/Calidi+Biotherapeutics+%28CLDI%29+Misses+Q1+EPS+by+43c/26497013.html <p>Calidi Biotherapeutics (NYSE: CLDI) reported Q1 EPS of ($0.43).</p><p>For earnings history and earnings-related data on Calidi Biotherapeutics (CLDI) <a href="http://www.streetinsider.com/ec_earnings.php?q=CLDI">click here</a>.</p> http://www.streetinsider.com/Earnings/Calidi+Biotherapeutics+%28CLDI%29+Misses+Q1+EPS+by+43c/26497013.html Thu, 14 May 2026 17:54:06 -0400 CLDI http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Calidi+Biotherapeutics%2C+++For%3A+Mar+31/26496011.html si-local-file:///var/storage/secattach/20260514/26496011.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Calidi+Biotherapeutics%2C+++For%3A+Mar+31/26496011.html Thu, 14 May 2026 16:41:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Calidi+Biotherapeutics%2C+++For%3A+Mar+31/26496011.html si-local-file:///var/storage/secattach/20260514/26496011.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Calidi+Biotherapeutics%2C+++For%3A+Mar+31/26496011.html Thu, 14 May 2026 16:41:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+14/26495195.html si-local-file:///var/storage/secattach/20260514/26495195.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+14/26495195.html Thu, 14 May 2026 16:16:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+14/26495195.html si-local-file:///var/storage/secattach/20260514/26495195.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+14/26495195.html Thu, 14 May 2026 16:16:00 -0400 CLDI O.51463149 http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Press+Releases/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html <p>SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel http://www.streetinsider.com/Globe+Newswire/Calidi+Biotherapeutics+Confirms+Featured+Speaker+Presentation+Tomorrow+at+the+ASGCT+Conference+in+Boston/26482036.html Wed, 13 May 2026 08:00:00 -0400 A.26566475 A.35552990 CLDI O.00074346 O.07320020 O.51463149 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+06/26462561.html si-local-file:///var/storage/secattach/20260508/26462561.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+06/26462561.html Fri, 08 May 2026 17:17:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+06/26462561.html si-local-file:///var/storage/secattach/20260508/26462561.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Calidi+Biotherapeutics%2C+++For%3A+May+06/26462561.html Fri, 08 May 2026 17:17:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Calidi+Biotherapeutics%2C++++++++++++++/26396588.html si-local-file:///var/storage/secattach/20260429/26396588.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Calidi+Biotherapeutics%2C++++++++++++++/26396588.html Wed, 29 Apr 2026 17:02:00 -0400 CLDI O.51463149 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Calidi+Biotherapeutics%2C++++++++++++++/26396588.html si-local-file:///var/storage/secattach/20260429/26396588.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Calidi+Biotherapeutics%2C++++++++++++++/26396588.html Wed, 29 Apr 2026 17:02:00 -0400 CLDI O.51463149